Get Integrated Data for Your Specialty and Interest Aresa
 
Category Select :
Items 181 ~ 200 of 26020, Page 10 of 1301
181. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agencys continued efforts to bring competition to the insulin market to lower prices and expand access - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
182. FDA takes new enforcement actions as part of the agencys ongoing effort to combat the illegal online sales of opioids - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
183. Statement on new steps to advance agencys continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
184. Merck Completes Tender Offer to Acquire Immune Design - 04/02/2019
 MERCK
185. USDA, EPA, and FDA Recognize April as Winning on Reducing Food Waste Month - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
186. Merck to Hold First-Quarter 2019 Sales and Earnings Conference Call on April 30 - 04/02/2019
 MERCK
187. Selumetinib Granted U.S. Breakthrough Therapy Designation in Neurofibromatosis Type 1 - 04/01/2019
 MERCK
  Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas / Selumetinib Is a MEK 1/2 Inhibitor Being Co-Developed by AstraZeneca and Merck
188. Merck Completes Acquisition of Antelliq Corporation to Become Leader in Emerging Digital Technology for Livestock and Companion Animals - 04/01/2019
 MERCK
189. Statement on new efforts to advance treatment strategies for helping youth addicted to nicotine as a result of the epidemic rise in teen use of e-cigarettes - 04/01/2019
 U.S. FOOD & DRUG ADMINISTRATION
190. FDA warns homeopathic firms for putting patients at risk with significant violations of manufacturing quality standards - 04/01/2019
 U.S. FOOD & DRUG ADMINISTRATION
191. Mercks KEYTRUDA (pembrolizumab) Approved in China for First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Combination with Chemotherapy - 04/01/2019
 MERCK
  KEYTRUDA is First Anti-PD-1 Therapy to be Approved in Multiple Tumor Types in China
192. Data for Mercks KEYTRUDA (pembrolizumab) Across Different Types of Advanced Lung Cancer Presented at AACR Annual Meeting 2019 - 04/01/2019
 MERCK
  First Presentation of Overall Survival Data from Post-Hoc Analysis of KEYNOTE-189 in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Who Have Liver or Brain Metastases / Pooled Data in Patients with Previously Treated Advanced Small Cell Lung Cancer in AACR 2019 Plenary Session and Press Conference
193. FDA approves new oral treatment for multiple sclerosis - 03/29/2019
 U.S. FOOD & DRUG ADMINISTRATION
194. Statement by FDA Commissioner Scott Gottlieb, M.D., Director of FDAs Center for Drug Evaluation and Research Janet Woodcock, M.D. and Director of FDAs Center for Biologics Evaluation and Research Peter Marks, M.D. on Expanded Access ?Looking Forward - 03/29/2019
 U.S. FOOD & DRUG ADMINISTRATION
195. FDA approves treatment for patients with a type of inflammatory arthritis - 03/28/2019
 U.S. FOOD & DRUG ADMINISTRATION
196. Statement on actions to advance our comprehensive plan to reduce tobacco-related disease and death, through new efforts to improve the tobacco product application review process, including a newly proposed rule - 03/28/2019
 U.S. FOOD & DRUG ADMINISTRATION
197. Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Subcommittee on Appropriations on FDAs Fiscal Year 2020 budget - 03/28/2019
 U.S. FOOD & DRUG ADMINISTRATION
198. FDA approves new oral testosterone capsule for treatment of men with certain forms of hypogonadism - 03/27/2019
 U.S. FOOD & DRUG ADMINISTRATION
199. Statement on new steps to strengthen agencys safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products - 03/27/2019
 U.S. FOOD & DRUG ADMINISTRATION
200. Grow Your Own Garden - 03/27/2019
 American Cancer Society
  Enjoy the outdoors, get some exercise, create beauty, and grow your own food all at the same time! Learn more about the benefits of working in your own garden.
<<  <  [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10>  >>
 


Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email : medalls@medalls.com